ask="2.93"
ask_size="100"
average_daily_volume="511062"
bid="2.30"
bid_size="500"
book_value="3.56"
change="-0.01"
change_from_200_day_moving_average="-2.02"
change_from_50_day_moving_average="0.37"
change_from_52_week_high="-6.60"
change_From_52_week_low="0.75"
change_in_percent="-0.36%"
close="2.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.03"
ebitda="-31.76M"
eps_estimate_current_year="-1.34"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-0.80"
ex_dividend_date="N/A"
float_shares="8386000"
high="2.84"
high_52_weeks="9.35"
last_trade_date="3/2/2017"
last_trade_price="2.75"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.73"
low_52_weeks="2.00"
market_capitalization="43.05M"
moving_average_200_day="4.77"
moving_average_50_day="2.38"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.63"
open="2.76"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-42.35%"
percent_change_from_50_day_moving_average="+15.57%"
percent_change_from_52_week_high="-70.59%"
percent_change_from_52_week_low="+37.50%"
previous_close="2.76"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.78"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15656000"
short_ratio="0.64"
stock_exchange="NGM"
symbol="NVLS"
volume="108994"
weeks_range_52="2.00 - 9.35"
